Tissue involution and the acute phase response

Annals of the New York Academy of Sciences

Volumn 995, Issue , 2003, Pages 94-108

  Nilsen Hamilton, Marit ^a   Liu, Quansheng ^b   Ryon, Joel ^a   Bendickson, Lee ^a   Lepont, Pierig ^c   Chang, Qing ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

24p3; Apoptosis; Mammary gland; Uterocalin; Uterus

Indexed keywords

ACUTE PHASE PROTEIN; CELL PROTEIN; FATTY ACID; UNCLASSIFIED DRUG; UTEROCALIN;

ACUTE PHASE RESPONSE; APOPTOSIS; BREAST CARCINOGENESIS; CONFERENCE PAPER; ENZYME DEGRADATION; ENZYME RELEASE; GENE MUTATION; HUMAN; INVOLUTION; LEUKOCYTE; MAMMARY GLAND FUNCTION; NEUTROPHIL; NONHUMAN; OXIDATION; PHAGOCYTOSIS; PREGNANCY; PROTEIN BINDING; PROTEIN EXPRESSION; REPRODUCTION; TISSUE REGENERATION; UTERUS;

EID: 0038806436     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03213.x     Document Type: Conference Paper

References (67)

1. LUND, L.R., J. ROMER, N. THOMASSET et al. 1996. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122: 181-193.
2. WAGNER, K.U., C.A. BOULANGER, M.D. HENRY et al. 2002. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 129: 1377-1386.
3. TAKAMOTO, N., P.C. LEPPERT & S.Y. YU. 1998. Cell death and proliferation and its relation to collagen degradation in uterine involution of rat. Connect. Tissue Res. 37: 163-175.
4. BALBIN, M., A. FUEYO, V. KNAUPER et al. 1998. Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes: analysis of its potential role in postpartum involution of the uterus. J. Biol. Chem. 273: 23959-23968.
5. FANG, Y., P. LEPONT, J. FASSETT et al. 1999. Signaling between the placenta and the uterus involving the mitogen-regulated protein/proliferins. Endocrinology 140: 5239-5274.
6. SUFFREDINI, A.F., G. FANTUZZI, R. BADOLATO et al. 1999. New insights into the biology of the acute phase response. J. Clin. Immunol. 19: 203-214.
7. LIU, Q. & M. NILSEN-HAMILTON. 1995. Identification of a new acute phase protein. J. Biol. Chem. 270: 22565-22570.
8. MEHEUS, L.A., L.M. FRANSEN, J.G. RAYMACKERS et al. 1993. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J. Immunol. 151: 1535-1547.
9. CERMELLI, S., B. ZEREGA, M. CARLEVARO et al. 2000. Extracellular fatty acid binding protein (ex-FABP) modulation by inflammatory agents: "physiological" acute phase response in endochondral bone formation. Eur. J. Cell Biol. 79: 155-164.
10. NILSEN-HAMILTON, M., R.T. HAMILTON & G.A. ADAMS. 1982. Rapid selective stimulation by growth factors of the incorporation by BALB/C 3T3 cells of [35S]methionine into a glycoprotein and five superinducible proteins. Biochem. Biophys. Res. Commun. 108: 158-166.
11. HRABA-RENEVEY, S., H. TURLER, M. KRESS et al. 1989. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 4: 601-608.
12. LIU, Q., J. RYON & M. NILSEN-HAMILTON. 1997. Uterocalin: a mouse acute phase protein expressed in the uterus around birth. Mol. Reprod. Dev. 46: 507-514.
13. RYON, J., L. BENDICKSON & M. NILSEN-HAMILTON. 2002. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem. J. I367: 271-277.
14. KJELDSEN, L., A.H. JOHNSEN, H. SENGELOV et al. 1993. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268: 10425-10432.
15. KJELDSEN, L., D.F. BAINTON, H. SENGELOV et al. 1994. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 83: 799-807.
16. BARTSCH, S. & H. TSCHESCHE. 1995. Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett. 357: 255-259.
17. TRIEBEL, S., J. BLASER, H. REINKE et al. 1992. A 25 kDa alpha-2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett. 314: 386-388.
18. ERSSON, A., M. WALLES, K. OHLSSON et al. 2002. Chronic hyperbaric exposure activates proinflammatory mediators in humans. J. Appl. Physiol. 92: 2375-2380.
19. LIN, Y., M.W. RAJALA, J.P. BERGER et al. 2001. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J. Biol. Chem. 276: 42077-42083.
20. BORREGAARD, N., M. SEHESTED, B.S. NIELSEN et al. 1995. Biosynthesis of granule proteins in normal human bone marrow cells: gelatinase is a marker of terminal neutrophil differentiation. Blood 85: 812-817.
21. LE CABEC, V., J.B. COWLAND, J. CALAFAT et al. 1996. Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells. Proc. Natl. Acad. Sci. USA 93: 6454-6457.
22. ELNEIHOUM, A.M., P. FALKE, L. AXELSSON et al. 1996. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 27: 1734-1738.
23. NIELSEN, O.H., P. GIONCHETTI, M. AINSWORTH et al. 1999. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. Am. J. Gastroenterol. 94: 2923-2928.
24. LAWRANCE, I.C., C. FIOCCHI & S. CHAKRAVARTI. 2001. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum. Mol. Genet. 10: 445-456.
25. FORSBLAD, J., A. GOTTSATER, K. PERSSON et al. 2002. Clinical manifestations of atherosclerosis in an elderly population are related to plasma neopterin, NGAL, and endothelin-1, but not to Chlamydia pneumoniae serology. Int. Angiol. 21: 173-179.
26. XU, S. & P. VENGE. 2000. Lipocalins as biochemical markers of disease. Biochim. Biophys. Acta 1482: 298-307.
27. STOESZ, S.P., A. FRIEDL, J.D. HAAG et al. 1998. Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int. J. Cancer 79: 565-572.
28. BRATT, T., S. OHLSON & N. BORREGAARD. 1999. Interactions between neutrophil gelatinase-associated lipocalin and natural lipophilic ligands. Biochim. Biophys. Acta 1472: 262-269.
29. ZEREGA, B., S. CERMELLI, B. MICHELIS et al. 2000. Expression of NRL/NGAL (neurelated lipocalin/neutrophil gelatinase-associated lipocalin) during mammalian embryonic development and in inflammation. Eur. J. Cell Biol. 79: 165-172.
30. DESCALZI CANCEDDA, F., B. DOZIN, B. ZEREGA et al. 2000. Ex-FABP: a fatty acid binding lipocalin developmentally regulated in chicken endochondral bone formation and myogenesis. Biochim. Biophys. Acta 1482: 127-135.
31. GENTILI, C., S. CERMELLI, C. TACCHETTI et al. 1998. Expression of the extracellular fatty acid binding protein (ex-FABP) during muscle fiber formation in vivo and in vitro. Exp. Cell Res. 242: 410-418.
32. LI, M., X. LIU, G. ROBINSON et al. 1997. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci. USA 94: 3425-3430.
33. BALL, R.K., R.R. FRIIS, C.A. SCHOENENBERGER et al. 1988. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7: 2089-2095.
34. SCHWOCHAU, G.B., K.A. NATH & M.E. ROSENBERG. 1998. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int. 53: 1647-1653.
35. BACH, U.C., M. BAIERSDORFER, G. KLOCK et al. 2001. Apoptotic cell debris and phosphatidylserine-containing lipid vesicles induce apolipoprotein J (clusterin) gene expression in vital fibroblasts. Exp. Cell Res. 265: 11-20.
36. FREIJE, J.M., I. DIEZ-ITZA, M. BALBIN et al. 1994. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269: 16766-16773.
37. ALLEN, R.A., R.W. ERICKSON & A.J. JESAITIS. 1989. Identification of a human neutrophil protein of Mr 24,000 that binds N-formyl peptides: co-sedimentation with specific granules. Biochim. Biophys. Acta 991: 123-133.
38. CHU, S., H. LIN, H. HUANG et al. 1998. The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins. J. Pept. Res. 52: 390-397.
39. CANCEDDA, F.D., M. MALPELI, C. GENTILI et al. 1996. The developmentally regulated avian Ch21 lipocalin is an extracellular fatty acid-binding protein. J. Biol. Chem. 271: 20163-20169.
40. PERSENGIEV, S.P., L.R. DEVIREDDY & M.R. GREEN. 2002. Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors. Genes Dev. 16: 1806-1814.
41. DEVIREDDY, L.R., J.G. TEODORO, F.A. RICHARD et al. 2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293: 829-834.
42. DAVIS, T.R., L. TABATABAI, K. BRUNS et al. 1991. Basic fibroblast growth factor induces 3T3 fibroblasts to synthesize and secrete a cyclophilin-like protein and beta-2-microglobulin. Biochim. Biophys. Acta 1095: 145-152.
43. GARAY-ROJAS, E., M. HARPER, S. HRABA-RENEVEY et al. 1996. An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene 170: 173-180.
44. HAMILTON, R.T., M. NILSEN-HAMILTON & G. ADAMS. 1985. Superinduction by cycloheximide of mitogen-induced secreted proteins produced by Balb/c 3T3 cells. J. Cell. Physiol. 123: 201-208.
45. LUETTEKE, N.C., T.H. QIU, S.E. FENTON et al. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126: 2739-2750.
46. BERG, M.N., A.M. DHARMARAJAN & B.J. WADDELL. 2002. Glucocorticoids and progesterone prevent apoptosis in the lactating rat mammary gland. Endocrinology 143: 222-227.
47. POYSER, N.L. 1981. Prostaglandin production by the uterus during early pregnancy. Acta Vet. Scand. Suppl. 77: 241-249.
48. IMLER, J.L. & J.A. HOFFMANN. 2000. Toll and toll-like proteins: an ancient family of receptors signaling infection. Rev. Immunogenet. 2: 294-304.
49. O'NEILL, L.A. 2002. Wanted: a molecular basis for specificity in toll-like receptor signal transduction. Mol. Cell 10: 969-971.
50. COWLAND, J.B. & N. BORREGAARD. 1997. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45: 17-23.
51. KUPER, H., H.O. ADAMI & D. TRICHOPOULOS. 2000. Infections as a major preventable cause of human cancer. J. Intern. Med. 248: 171-183.
52. ERNST, P.B. & B.D. GOLD. 2000. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol. 54: 615-640.
53. NESS, R.B., J.A. GRISSO, C. COTTREAU et al. 2000. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 11: 111-117.
54. COLLET, J.P., C. SHARPE, E. BELZILE et al. 1999. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br. J. Cancer 81: 62-68.
55. BERNATSKY, S., A. CLARKE & R. RAMSEY-GOLDMAN. 2002. Malignancy and systemic lupus erythematosus. Curr. Rheumatol. Rep. 4: 351-358.
56. DE MARZO, A.M., V.L. MARCHI, J.I. EPSTEIN et al. 1999. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am. J. Pathol. 155: 1985-1992.
57. ERNST, P. 1999. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment. Pharmacol. Ther. 13(suppl. 1): 13-18.
58. SHORTER, R.G. 1983. Risks of intestinal cancer in Crohn's disease. Dis. Colon Rectum 26: 686-689.
59. LEVIN, B. 1992. Ulcerative colitis and colon cancer: biology and surveillance. J. Cell. Biochem. Suppl. 16G: 47-50.
60. ZHANG, Z., G.C. KUNDU, D. PANDA et al. 1999. Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene. Proc. Natl. Acad. Sci. USA 96: 3963-3968.
61. NEWCOMB, P.A., B.E. STORER, M.P. LONGNECKER et al. 1994. Lactation and a reduced risk of premenopausal breast cancer. N. Engl. J. Med. 330: 81-87.
62. RUSSO, J. & I.H. RUSSO. 1980. Susceptibility of the mammary gland to carcinogenesis: II. Pregnancy interruption as a risk factor in tumor incidence. Am. J. Pathol. 100: 497-512.
63. ABRAMS, T.J., R.C. GUZMAN, S.M. SWANSON et al. 1998. Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis. Anticancer Res. 18: 4115-4121.
64. D'CRUZ, C.M., S.E. MOODY, S.R. MASTER et al. 2002. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol. Endocrinol. 16: 2034-2051.
65. SAVILL, J.S., A.H. WYLLIE, J.E. HENSON et al. 1989. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83: 865-875.
66. DIGIOVANNI, J. & M.R. JUCHAU. 1980. Biotransformation and bioactivation of 7,12-dimethylbenz[a]anthracene (7,12-DMBA). Drug Metab. Rev. 11: 61-101.
67. JOSEPHY, P.D. & B.L. COOMBER. 1998. The 1996 Veylien Henderson Award of the Society of Toxicology of Canada. Current concepts: neutrophils and the activation of carcinogens in the breast and other organs. Can. J. Physiol. Pharmacol. 76: 693-700.